Prescription Drug Trade-Off: Lower Premiums, Higher Out-of-Pocket Costs in Vertical Integration
Ownership of the prescription drug supply chain by a single large company can lower insurance premiums for consumers but leads to higher out-of-pocket costs for many, according to a May 2026 audit report. The audit conducted by the Office of Inspector General for the Department of Health and Human Services studied the impact of “vertical